Abstract
Aim: Using the USPTF guidelines to evaluate the adherence of a community hospital resident clinic to Primary prevention of CVD: use of aspirin, statins and smoking cessation. Proper implementation of these guidelines has potential to benefit millions of patients and also reduce the health care cost secondary to cardiovascular diseases Methods: Inclusion and exclusion criteria were defined. Inclusion criteria: -65 2014 – April 2015) Exclusion criteria: Retrospective EMR chart review was performed. Use of aspirin, statin type and dose, allergy/ contraindication to these medications and current smoking status were tabulated. Results: Only 39% (372) of these patients were on aspirin for primary prevention. 66% (630) patients had an ASCVD risk score of more than 7.5, qualifying them for statin therapy. Out of these only 48%(302) were on optimal statin therapy, while 49%( 309) were on suboptimal and 3%(19) were on no statin therapy. 58% (554) of the studies population was smoker in the studies population, despite documented counseling efforts by the clinicians. Conclusions: The compliance to USPTF guidelines for primary prevention of CVD in resident clinic in community setting was much less than desired. Various educational measures including resident conferences and a reminder in the EMR has potential to increase the adherence to these guidelines.